Letter to the Treasury Department on Chinese Control of U.S. Medical Technology

Chairman John Moolenaar sent a letter to Treasury Secretary Scott Bessent requesting immediate CFIUS action against a Chinese pharmaceutical company's controlling investment in FastWave Medical, a U.S. developer of laser-based intravascular lithotripsy technology. The letter argues the investment threatens national security by risking extraction of dual-use technology and undermining American medical innovation and jobs.